Findings

What do systematic reviews say?

2 questions · 2 findings · 2 reviews · Kidney and Transplant

No studies found 1 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 50%High 0 · 0%

All‐cause mortality: CERA every 2 weeks versus rHuEPO · patients with the anaemia of end‐stage kidney disease undergoing dialysis

CERA showed no clear difference in all‐cause mortality: CERA every 2 weeks versus rHuEPO compared with other ESA (moderate certainty).

1 finding from 1 review

All‐cause mortality · CKD patients (any stage) treated for anaemia

The review found no eligible studies for this question.

1 finding from 1 review

Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found